Ling Han

A highly potent small-molecule antagonist of exportin-1 selectively eliminates CD44+CD24- enriched breast cancer stem-like cells.

Jinchi Liu, Dongyu Zhao, Caigang Liu, 2022, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

Multicentre, prospective, randomised controlled trial to evaluate hexaminolevulinate photodynamic therapy (Cevira) as a novel treatment in patients with high-grade squamous intraepithelial lesion: APRICITY phase 3 study protocol

P. Hillemanns, L. Sui, Youzhong Zhang, 2021, BMJ Open.

An herbal drug combination identified by knowledge graph alleviates the clinical symptoms of plasma cell mastitis patients: A nonrandomized controlled trial

Dongyu Zhao, Caigang Liu, Yongliang Yang, 2022, medRxiv.